| |
| |
|
| Insider
Information: |
Corrigan Mark |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
29,062 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,837 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
29,062 |
|
|
| Total
Value |
$2,837 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -200.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Epirus Biopharmaceuticals Inc |
EPRS |
Director |
2014-07-15 |
21,859 |
|
0 |
Premium* |
|
|
Nabriva Therapeutics AG |
NBRV |
Director |
2022-08-02 |
7,203 |
2021-07-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2022-08-02 |
4 |
S |
$0.19 |
$1,956 |
D/D |
(10,297) |
7,203 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2021-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
17,500 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2014-07-15 |
4 |
D |
$11.80 |
$172,245 |
D/D |
(14,597) |
21,859 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
President & CEO |
• • – |
2014-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
364,567 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
President & CEO |
• • – |
2014-01-15 |
4 |
D |
$1.66 |
$30,011 |
D/D |
(18,079) |
114,567 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
President & CEO |
• • – |
2014-01-03 |
4 |
D |
$1.22 |
$9,803 |
D/D |
(8,035) |
132,646 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
President & CEO |
• • – |
2013-01-15 |
4 |
S |
$0.77 |
$86,895 |
D/D |
(112,850) |
844,090 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
President & CEO |
• • – |
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
956,940 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
President & CEO |
• • – |
2012-01-17 |
4 |
AS |
$1.14 |
$77,640 |
D/D |
(68,105) |
706,940 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
President & CEO |
• • – |
2011-01-18 |
4 |
AS |
$2.18 |
$135,509 |
D/D |
(62,160) |
775,045 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
President & CEO |
• • – |
2010-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
799,048 |
837,205 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
President & CEO |
• • – |
2010-03-01 |
4 |
D |
$1.11 |
$25,327 |
D/D |
(22,817) |
38,157 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2010-01-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,111) |
38,157 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2009-12-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
68,268 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
